TMVR

Device LivaNova USA, Inc.
Total Payments
$812,043
Transactions
365
Doctors
53
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2021 $44,046 24 0
2020 $39,025 12 1
2019 $448,449 207 29
2018 $280,524 122 33

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $696,423 188 85.8%
Travel and Lodging $61,694 74 7.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $29,760 18 3.7%
Consulting Fee $21,266 13 2.6%
Food and Beverage $2,901 72 0.4%

Payments by Type

Research
$696,423
188 transactions
General
$115,621
177 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
The TMVR System, PRELUDE Study LivaNova USA, Inc. $246,252 0
Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study PRELUDE LivaNova USA, Inc. $189,789 0
The TMVR System, INTERLUDE Study LivaNova USA, Inc. $130,435 0
Clinical Investigation of the Caisson Transcatheter Mitral Valve Replacement TMVR System for Percutaneous Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation LivaNova USA, Inc. $55,005 0
Prelude/Interlude LivaNova USA, Inc. $44,046 0
PRELUDE Study LivaNova USA, Inc. $30,896 0

Top Doctors Receiving Payments for TMVR — Page 3

Doctor Specialty Location Total Records
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Minneapolis, MN $24.01 1
, MD Internal Medicine Birmingham, AL $13.89 1
, MD Cardiovascular Disease Liverpool, NY $13.89 1
, M.D Anesthesiology Lincoln, NE $11.57 1

About TMVR

TMVR is a device associated with $812,043 in payments to 53 healthcare providers, recorded across 365 transactions in the CMS Open Payments database. The primary manufacturer is LivaNova USA, Inc..

Payment data is available from 2018 to 2021. In 2021, $44,046 was paid across 24 transactions to 0 doctors.

The most common payment nature for TMVR is "Unspecified" ($696,423, 85.8% of total).

TMVR is associated with 6 research studies, including "The TMVR System, PRELUDE Study" ($246,252).